JPMorgan Chase & Co’s Terns Pharmaceuticals TERN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.34M | Buy |
358,206
+64,011
| +22% | +$239K | ﹤0.01% | 3580 |
|
|
2025
Q1 | $812K | Buy |
294,195
+242,365
| +468% | +$669K | ﹤0.01% | 3764 |
|
|
2024
Q4 | $287K | Sell |
51,830
-7,706
| -13% | -$42.7K | ﹤0.01% | 4390 |
|
|
2024
Q3 | $497K | Sell |
59,536
-93,544
| -61% | -$780K | ﹤0.01% | 4013 |
|
|
2024
Q2 | $1.04M | Sell |
153,080
-268,557
| -64% | -$1.83M | ﹤0.01% | 3487 |
|
|
2024
Q1 | $2.77M | Buy |
421,637
+203,436
| +93% | +$1.33M | ﹤0.01% | 2940 |
|
|
2023
Q4 | $1.42M | Sell |
218,201
-64,934
| -23% | -$421K | ﹤0.01% | 3333 |
|
|
2023
Q3 | $1.42M | Sell |
283,135
-98,480
| -26% | -$495K | ﹤0.01% | 3208 |
|
|
2023
Q2 | $3.34M | Sell |
381,615
-250,131
| -40% | -$2.19M | ﹤0.01% | 2738 |
|
|
2023
Q1 | $7.48M | Sell |
631,746
-575,405
| -48% | -$6.81M | ﹤0.01% | 2199 |
|
|
2022
Q4 | $12.3M | Buy |
1,207,151
+288,109
| +31% | +$2.93M | ﹤0.01% | 1759 |
|
|
2022
Q3 | $5.41M | Buy |
919,042
+918,079
| +95,335% | +$5.41M | ﹤0.01% | 2287 |
|
|
2022
Q2 | $2K | Sell |
963
-8,404
| -90% | -$17.5K | ﹤0.01% | 5431 |
|
|
2022
Q1 | $28K | Buy |
9,367
+1,923
| +26% | +$5.75K | ﹤0.01% | 5202 |
|
|
2021
Q4 | $52K | Buy |
7,444
+2,190
| +42% | +$15.3K | ﹤0.01% | 5060 |
|
|
2021
Q3 | $55K | Sell |
5,254
-6,165
| -54% | -$64.5K | ﹤0.01% | 4934 |
|
|
2021
Q2 | $140K | Sell |
11,419
-12,117
| -51% | -$149K | ﹤0.01% | 4651 |
|
|
2021
Q1 | $518K | Buy |
+23,536
| New | +$518K | ﹤0.01% | 4025 |
|